NCT00645463View on ClinicalTrials.gov

Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

June 30, 2007

Conditions
Obesity
Interventions
DRUG

CP-945,598

20 mg CP-945,598 + 240 mg MR Diltiazem

DRUG

CP-945,598

20 mg CP-945,598 alone

Trial Locations (1)

48105

Pfizer Investigational Site, Ann Arbor

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00645463 - Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics | Biotech Hunter | Biotech Hunter